InnoCare Announces First Subject Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in China
InnoCare Pharma announced today that the first subject has been dosed in clinical trial of the Company’s B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in China.
Uncategorized
AusperBio Announces First-in-Human Dosing of AHB-137, an Antisense Oligonucleotide Drug Candidate for the Treatment of Chronic Hepatitis B
Ausper Biopharma Co., Ltd. and AusperBio Therapeutic, Inc. today announced the completion of the first cohort dosing in a Phase 1 clinical trial evaluating AHB–137 in adult healthy volunteers and chronic hepatitis B (CHB) patients in New Zealand.
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
Allorion Therapeutics (“Allorion”), a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a $50 million Series B financing round.
Biden’s proposed HHS budget aims to make pandemic-era subsidies permanent
Released Thursday, the budget also proposes to extend Medicare solvency and give the federal government more power to negotiate prescription drug prices.
Biden’s proposed HHS budget aims to make pandemic-era subsidies permanent Read More »
Telehealth use rose at end of last year, Fair Health finds
COVID-19 stayed as the third top telehealth diagnosis nationally and accounted for a larger share of claims in December, Fair Health found.
Telehealth use rose at end of last year, Fair Health finds Read More »
Clene’s Nanocrystal ALS Treatment Bounces Back with Positive Data
Despite missing the initial mark, new analysis of Clene’s gold nanocrystal therapy from the HEALEY ALS trial indicates the asset still shows promise.
Clene’s Nanocrystal ALS Treatment Bounces Back with Positive Data Read More »
Titan delisted from Nasdaq, as surgical robot maker struggles to sell assets
Titan’s robotic surgery device faced delays in development that forced the firm to put off a planned FDA submission. The company has laid off its technical staff as it seeks to sell its assets.
Titan delisted from Nasdaq, as surgical robot maker struggles to sell assets Read More »
California cancels $54M Walgreens contract over company’s decision to not sell abortion pills
California Gov. Gavin Newsom is making good on his threat to no longer do business with Walgreens over abortion pill access, illustrating how the drugstore industry is attempting to navigate shifting state abortion laws.
Bayer Plans to Double Down on US Pharma R&D in 2023
Bayer plans to substantially increase investment in U.S.-based pharmaceutical R&D, earmarking $1 billion to invest stateside in 2023.
Bayer Plans to Double Down on US Pharma R&D in 2023 Read More »
How ChatGPT Can–and Can’t–Help Your Job Search
Can ChatGPT help you find a new job in an industry as complex as the life sciences? BioSpace’s career editor decided to put it to the test – here’s what she discovered.